Generex Biotechnology granted new U.S. drug delivery patent
Patent covers broad claims for the delivery of macromolecules via the buccal cavity of the mouth
Generex Biotechnology Corporation announced that the United States Patent and Trademark Office has granted the Company a new United States Patent entitled Methods of Administering and Enhancing absorption of Pharmaceutical Agents. The patent covers broad claims for the delivery of macromolecules via the buccal cavity of the mouth.
The patent relates to the Company's proprietary methodologies for the production of safe and effective oral formulations for the delivery of macromolecular pharmaceutical agents into the human body via the buccal region of the mouth. The process involves the creation of a stable mixed micellar solution containing the pharmaceutical agent, absorption enhancers, and other excipients. When the solution is introduced to the buccal mucosa, the result is increased bioavailability of the active drug and more rapid onset of action.
Most read news
Organizations
Other news from the department research and development
![Newsletter](https://img.chemie.de/assets/awportal/images/newsletter.png)
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.